Talks in this session will include new approaches to process development in both upstream and downstream areas that together present significant improvements to speed in the development and implementation of commercial drug substance processes. The use of automation and high-throughput systems, accelerated learning through data capture and mining, more reliable scale-down models and potentially disruptive technologies are examples of topics that should be considered for talks and discussion.
Brian Kelley, Genentech
Nigel Titchener-Hooker, University College London
- Gene Schaefer, Johnson & Johnson: Challenges and Innovative Approaches to Improving the Efficiencies of Process Development and Tech Transfer
- Rohin Mahtre, Biogen Idec: Enhancing Efficiency and Control for a Biopharamaceutical Manufacturing Process
- Mike Hoare, University College London: Speeding Whole Bioprocess Solutions: the Crucial Interface Linking the Bioreactor to Purification
- Dean Pettit, Amgen: Upstream and Downstream Strategies to Actively Control of Product Quality Attributes